Literature DB >> 19763774

Admission of Parkinsonian patients to a neurological ward in a community hospital.

Colin Klein1, Tatiana Prokhorov, Ala Miniovitz, Eugenia Dobronevsky, Jose Martin Rabey.   

Abstract

Hospitalization is a significant factor contributing to health care costs related to management of Parkinson's disease (PD) patients. We reviewed reasons for admission of PD patients to our Neurological Department over a 6-year period. Thereafter, we applied an "open door" policy to try to diminish the number of hospitalizations. Case records including patient data, disease duration, staging, reasons for admission, and motor, mental and general medical status of PD patients admitted to the Neurology Department over a 6-year period were reviewed. Out of 1,920 admissions, 143 were PD patients. All PD admissions were through the emergency department (non-elective). Motor complications were the reason for admission in 37%, psychosis in 24%, general medical problems in 14%, and a combination of motor and psychiatric in 25%. Drug-induced psychosis was the most significant cause of repeated and prolonged admissions (29% of patients). As motor and psychiatric complications are the commonest causes for admission, improved community-based care to "fine tune" medication appeared to be a priority. After analyzing our results, we instituted an "open door" policy, where patients are free to come to the Parkinson's clinic without appointment. This policy should improve control of PD symptoms and diminish hospitalizations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763774     DOI: 10.1007/s00702-009-0302-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  12 in total

Review 1.  Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.

Authors:  R T Scheife; G T Schumock; A Burstein; M D Gottwald; M S Luer
Journal:  Am J Health Syst Pharm       Date:  2000-05-15       Impact factor: 2.637

2.  Parkinsonism in Ontario: comorbidity associated with hospitalization in a large cohort.

Authors:  Mark Guttman; Pamela M Slaughter; Marc-Erick Theriault; Donald P DeBoer; C David Naylor
Journal:  Mov Disord       Date:  2004-01       Impact factor: 10.338

3.  Comorbid disorders and hospitalisation in Parkinson's disease: a prospective study.

Authors:  E Martignoni; L Godi; A Citterio; R Zangaglia; G Riboldazzi; D Calandrella; C Pacchetti; G Nappi
Journal:  Neurol Sci       Date:  2004-06       Impact factor: 3.307

4.  Burden of parkinsonism: a population-based study.

Authors:  Mark Guttman; Pamela M Slaughter; Marc-Erick Theriault; Donald P DeBoer; C David Naylor
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

5.  Risk factors for nursing home placement in advanced Parkinson's disease.

Authors:  C G Goetz; G T Stebbins
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

6.  The profile of hospitalised patients with Parkinson's disease.

Authors:  L C Tan; A K Tan; H T Tjia
Journal:  Ann Acad Med Singapore       Date:  1998-11       Impact factor: 2.473

Review 7.  Emergency department presentations of patients with Parkinson's disease.

Authors:  S A Factor; E S Molho
Journal:  Am J Emerg Med       Date:  2000-03       Impact factor: 2.469

8.  Reasons for admission to hospital for Parkinson's disease.

Authors:  J A Temlett; P D Thompson
Journal:  Intern Med J       Date:  2006-08       Impact factor: 2.048

9.  Parkinson's disease as community health problem: study in Norwegian nursing homes. The Norwegian Study Group of Parkinson's Disease in the Elderly.

Authors:  J P Larsen
Journal:  BMJ       Date:  1991-09-28

10.  The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease.

Authors:  S L Mitchell; D K Kiely; D P Kiel; L A Lipsitz
Journal:  J Am Geriatr Soc       Date:  1996-04       Impact factor: 5.562

View more
  13 in total

1.  Neurologist-associated reduction in PD-related hospitalizations and health care expenditures.

Authors:  Allison W Willis; Mario Schootman; Rebecca Tran; Nathan Kung; Bradley A Evanoff; Joel S Perlmutter; Brad A Racette
Journal:  Neurology       Date:  2012-10-10       Impact factor: 9.910

2.  Hospitalization in Parkinson disease: a survey of National Parkinson Foundation Centers.

Authors:  Kelvin L Chou; Jorge Zamudio; Peter Schmidt; Catherine C Price; Sotirios A Parashos; Bastiaan R Bloem; Kelly E Lyons; Chadwick W Christine; Rajesh Pahwa; Ivan Bodis-Wollner; Wolfgang H Oertel; Oksana Suchowersky; Michael J Aminoff; Irene A Malaty; Joseph H Friedman; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2011-04-01       Impact factor: 4.891

3.  Parkinson's disease increases the risk of perioperative complications after total knee arthroplasty: a nationwide database study.

Authors:  Jared M Newman; Nipun Sodhi; Alyeesha B Wilhelm; Anton Khlopas; Alison K Klika; Qais Naziri; Thomas J Kryzak; Carlos A Higuera; Michael A Mont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-05-21       Impact factor: 4.342

Review 4.  Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines.

Authors:  Michael J Aminoff; Chad W Christine; Joseph H Friedman; Kelvin L Chou; Kelly E Lyons; Rajesh Pahwa; Bastian R Bloem; Sotirios A Parashos; Catherine C Price; Irene A Malaty; Robert Iansek; Ivan Bodis-Wollner; Oksana Suchowersky; Wolfgang H Oertel; Jorge Zamudio; Joyce Oberdorf; Peter Schmidt; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2010-12-14       Impact factor: 4.891

Review 5.  Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis.

Authors:  Harini Sarva; Claire Henchcliffe
Journal:  Ther Adv Neurol Disord       Date:  2016-10-03       Impact factor: 6.570

Review 6.  Review of delirium in patients with Parkinson's disease.

Authors:  Emma R L C Vardy; Andrew Teodorczuk; Alison J Yarnall
Journal:  J Neurol       Date:  2015-05-10       Impact factor: 4.849

Review 7.  The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

Authors:  Daniel Weintraub; Eugenia Mamikonyan
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-09       Impact factor: 4.105

8.  Inpatient management of Parkinson disease: current challenges and future directions.

Authors:  Odinachi Oguh; Aleksandar Videnovic
Journal:  Neurohospitalist       Date:  2012-01

Review 9.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

10.  Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Sarah Horn; Hayley Richardson; Sharon X Xie; Daniel Weintraub; Nabila Dahodwala
Journal:  Parkinsonism Relat Disord       Date:  2019-11-11       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.